MetaCurUm Biotech
Pre-clinicalMetaCurUm Biotech is developing a novel treatment that will benefitpatients with aggressive cancer.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
MetaCurUm Biotech is developing a novel treatment that will benefitpatients with aggressive cancer.
AntibodiesBiologics